Clinical trial · Interventional
Music Therapy For The Treatment Of Cisplatin Induced Tinnitus In Patients With rGCC: A Pilot Study
Music Therapy For The Treatment Of Cisplatin Induced Tinnitus In Patients With Relapsed Germ Cell Cancer (rGCC): A Pilot Study
NCT04402593CI-TRIAL-00067387withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Due to staffing changes and no potential subjects at this time.
Summary
Brief summary (as posted)
Pilot study evaluating the feasibility of recruitment, retention, and compliance to a modified Heidelberg Model of Neuro-Music Therapy (mHNMT) in patients with Cisplatin-induced Tinnitus and relapsed Germ Cell Cancer (rGCC).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cisplatin Induced Tinnitus | — | UNRESOLVED | — |
| Relapsed Germ Cell Cancer | Malignant Germ Cell Tumor | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Modified Heidelberg Model of Neuro-Music Therapy | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Modified Heidelberg Model of Neuro-Music Therapy (mHNMT)
- description
- The mHNMT for Tinnitus program was modified based on participant feedback of the original HNMT. This study will include 6 sessions, 2 sessions a week including the following interventions: resonance training, music relaxation, Intonation Training and session review/homework.
- interventionNames
- Behavioral: Modified Heidelberg Model of Neuro-Music Therapy
Primary outcomes (3)
- measure
- Recruitment feasibility
- timeFrame
- 30 days
- description
- The ability to enroll at least 50% of approached subjects.
- measure
- Retention feasibility
- timeFrame
- from the start of intervention until last subject completes intervention (i.e. up to 2 years)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. ≥ 18 years old at the time of informed consent. 2. English speaking. 3. Ability to provide written informed consent and HIPAA authorization 4. Confirmed diagnosis of CIT via a score on the TFI of 26 or greater. 5. Personal history of rGCC. 6. Previous exposure to cisplatin. 7. Admitted to BMT service to undergo HDC-tBMR for the first time. (Because this is a feasibility study, a minimum number of MT sessions will not be required). 8. Agrees not to receive music therapy outside of study. Exclusion Criteria: 1. Severe hearing impairment greater than 60 dB HL in the region of the center tinnitus frequency 2. Patient's tinnitus can not be pitch matched. 3. Clinical diagnosis of severe mental disorder or psychiatric or neurological disease such as psychosis, epilepsy, Parkinson's disease, dementia, alcohol or drug abuse.
References
Publications (0)
Data not yet available
No reference posted for this study.